SmartTarget ^Company

Evidence is mounting rapidly with regards to the patient benefit of a prostate cancer care pathway guided by MR imaging and targeted biopsy. Clinicians at University College London Hospitals have been working over the past five years with researchers in UCLвАЩs Centre for Medical Image Computing to develop an image fusion software for transperineal targeting of the prostate. The resulting CE-marked SmartTarget¬Ѓ device is specifically designed to be agnostic to the clinicвАЩs MR and ultrasound equipment, intuitive for the user, fast to set up and slipping easily into existing clinical workflows with minimal disruption. Having also benefitted from funding by the UKвАЩs Department of Health and the Wellcome Trust, we are pleased to offer a system that is affordable for both the public and private healthcare sectors.